Connect with us

Legal & Regulation

M3 Ventures Cannabis Company Fined $50,000 By Massachusetts Regulators Over Pesticide Use

Denis Mariti

Published

on

M3 Ventures Cannabis Company Fined $50,000 By Massachusetts Regulators Over Pesticide Use

M3 Ventures, a Plymouth-based cannabis company, is set to pay a $50,000 fine for giving false information about their pesticide use.

According to a MassLive report, an M3 Ventures employee lied to the Massachusetts Cannabis Control Commission about the pesticides the company used to cultivate cannabis. However, Commission chairman Steven Hoffman said that M3 Ventures has “rectified” the issue in a number of ways.

Initially, state inspectors had shut down the company’s dispensaries in Mashpee and Plymouth in December over their pesticide use, but permitted them to reopen in April.

Inspectors found out the prohibited pesticides at the cultivation facility of M3 in November and interviewed the cultivation director about its use. During the following month’s inspection, the company brass admitted that the use of pesticides had been misrepresented by the cultivation director, hence causing closure and fines.

As a result, the company split the position of cultivator director into two – master grower and cultivation operations manager. M3 also partnered with a national firm to help them in developing a plan for cannabis pest management through the use of approved substances.

On top of the fine, the company was put on administrative probation until the end of the year, and has been required to track and record its use of additives daily.

During a press meeting on Thursday, Paul Payer, cannabis control commission enforcement course, said that M3 has not violated any state regulations from the time it reopened, and that the company had taken further steps to comply with the settlement which reflects integrity required by regulators when licensing candidates.

In March, state regulators carried out investigations into two other cannabis companies – acreage holdings and Sea Hunter Therapeutics – to see whether they flouted company ownership rules through using the state regulations’ loopholes to hide their affiliations through using shell companies. This case is still going on.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading
Ultimate CBD Guide

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

CBD News Updates

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational purposes only.

Got news? Email contact@timesofcbd.com